
|Videos|May 7, 2015
How Biosimilar Drug Approvals Provide Opportunities for Pharmacists
Fred Eckel, RPh, MS, Editor-in-Chief of Pharmacy Times, reflects on how pharmacists will be affected by FDA approvals of biosimilars.
Advertisement
Fred Eckel, RPh, MS, Editor-in-Chief of Pharmacy Times, reflects on how pharmacists will be affected by FDA approvals of biosimilars.
This video was recorded at APhA’s Annual Meeting and Exposition in March 2015.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Predictive Models Could Address Missing Data in Advanced Prostate Cancer
2
FDA Approves Apitegromab-mstn, First Muscle-Targeted SMA Therapy
3
Ivonescimab Significantly Extends OS Over Pembrolizumab in PD-L1-Positive Advanced NSCLC
4
CGM and Ketone Data Reshape Pharmacist-Led Diabetes Care: Insights From NEIAP 2026
5




































































































